CCS launches Scientific Advisory Council 

DALLAS – CCS has launched a Scientific Advisory Council comprised of four industry leaders who, it says, will support the company in its commitment to redefining patient care at home through a more holistic approach. They are: Alexander Ding, MD; Karmeen Kulkarni, MS, RD, CD, CDCES, BC-ADM; Steven Wittlin, MD; and Francine Kaufman, MD. The announcement of the new council follows CCS’s news that it has hired its first chief medical officer, Arti Masturzo, MD. “Dr. Masturzo has assembled a multi-stakeholder group of experts to comprise our newly formed Scientific Advisory Council,” said Tony Vahedian, CEO at CCS. “Dr. Ding, Ms. Kulkarni, Dr. Wittlin and Dr. Kaufman each bring unique industry expertise to the council. Arti will lead the council in helping to inform new approaches to simplifying chronic care management for the patients we serve.” More info about the council members: 

• Ding is a practicing diagnostic and interventional radiologist, associate vice president of physician strategy and medical affairs at Humana, and a board member of the American Medical Association.  

• Kulkarni is a global clinical leader in diabetes management with more than 30 years of experience. Prior to spearheading her own consulting group, she spent 15 years with Abbott as the director of global scientific affairs. 

• Wittlin is an endocrinologist, frequently published author and director of diabetes services at the University of Rochester. 

• Kaufman is a practicing pediatric endocrinologist, Distinguished Professor Emerita of Pediatrics at the Keck School of Medicine of the University of Southern California and Children's Hospital Los Angeles, and the former president of the American Diabetes Association. She is the chief medical officer at Senseonics and previously held the same position at Medtronic Diabetes.